Cite
Martín-Cámara O, Arribas M, Wells G, et al. Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis. J Med Chem. 2022;doi: 10.1021/acs.jmedchem.1c01255.
Martín-Cámara, O., Arribas, M., Wells, G., Morales-Tenorio, M., Martín-Requero, �. �., Porras, G., Martínez, A., Giorgi, G., López-Alvarado, P., Lastres-Becker, I., & Menéndez, J. C. (2022). Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis. Journal of medicinal chemistry, . https://doi.org/10.1021/acs.jmedchem.1c01255
Martín-Cámara, Olmo, et al. "Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis." Journal of medicinal chemistry vol. (2022). doi: https://doi.org/10.1021/acs.jmedchem.1c01255
Martín-Cámara O, Arribas M, Wells G, Morales-Tenorio M, Martín-Requero Á, Porras G, Martínez A, Giorgi G, López-Alvarado P, Lastres-Becker I, Menéndez JC. Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis. J Med Chem. 2022 Jan 05; doi: 10.1021/acs.jmedchem.1c01255. Epub 2022 Jan 05. PMID: 34985276.
Copy
Download .nbib